HkRoids
Finnrick has tested 55 samples from HkRoids across 7 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| BPC-157 | 8 | 29 Dec 2025 | 1 Jun 2026 | |||||
| GHK-Cu | 5 | 4 Aug 2025 | 1 Jun 2026 | |||||
| Retatrutide | 14 | 4 Aug 2025 | 13 May 2026 | |||||
| Tesamorelin | 8 | 25 Nov 2025 | 1 Jun 2026 | |||||
| Ipamorelin | 6 | 22 Nov 2025 | 1 Jun 2026 | |||||
| CJC-1295 | 5 | 6 Dec 2025 | 1 Jun 2026 | |||||
| Tirzepatide | 9 | 3 Jul 2025 | 21 Apr 2026 | |||||
The HkRoids samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent HkRoids tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 1 Jun 2026 | CJC-1295 | View | 10mg | ⚠️ Sample does not contain CJC-1295 | 0392 | No label / Silver crimp / Blue cap | Lab G | Public | |||
| 1 Jun 2026 | BPC-157 | View | 10mg | 10.4mg | +4.0% | 99.80% | 0388 | No label / Silver crimp / Black cap | Lab G | Public | |
| 1 Jun 2026 | Tesamorelin | View | 10mg | 12.6mg | +26.0% | 99.50% | 0392 TSM10 | No label / Silver crimp / Green cap | Lab G | Public | |
| 1 Jun 2026 | GHK-Cu | View | 100mg | 71.2mg | -28.8% | 99.70% | 0392 | No label / Silver crimp / Blue cap | Lab G | Public | |
| 1 Jun 2026 | Ipamorelin | View | 10mg | ⚠️ Sample does not contain Ipamorelin | IP10 0392 | No label / Silver crimp / Blue cap | Lab G | Public | |||
| 27 May 2026 | BPC-157 | View | 5mg | 4.15mg | -17.0% | 99.90% | 0412 | White label / Silver crimp / White cap | Lab E | Public | |
| 27 May 2026 | BPC-157 | View | 5mg | 4.08mg | -18.4% | 99.90% | 0412 | White label / Silver crimp / White cap | Lab E | Public | |
About HkRoids Test Results From Finnrick
HkRoids is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 7 products and 55 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud). Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
HkRoids Testing Activity & Score Summary
In the past 30 days, Finnrick has published no new test results for HkRoids, and 13 in the past three months. The overall dataset includes 55 tested samples with an average score of 7.4/10 across all products.
Across 55 identity-tested samples, 96% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.8%. Approximately 92% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Retatrutide (14 tests, 100% identity pass, median purity 99.7%) — Test scores are highly variable, ranging from 5.8 to 9.9 (average 7.7/10), suggesting significant batch-to-batch differences.
- BPC-157 (8 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 6.8 to 10.0 (average 8.3/10), suggesting significant batch-to-batch differences.
- Tesamorelin (8 tests, 100% identity pass, median purity 99.7%) — Test scores are highly variable, ranging from 4.3 to 10.0 (average 7.2/10), suggesting significant batch-to-batch differences.